Kazuma Fujita

机构：Osaka University of Economics, Akita University, Osaka Prefectural Toyonaka Support School, Akita University Hospital · ORCID：0000-0002-8914-9164

发表论文 46 篇 · 总被引 411 次 · h-index 12

代表论文

Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer (2019 · Scientific Reports · 被引 49)
Quantitative determination of regorafenib and its two major metabolites in human plasma with high‐performance liquid chromatography and ultraviolet detection (2016 · Biomedical Chromatography · 被引 30)
Effects of SLC31A1 and ATP7B polymorphisms on platinum resistance in patients with esophageal squamous cell carcinoma receiving neoadjuvant chemoradiotherapy (2021 · Medical Oncology · 被引 22)
Therapeutic drug monitoring of regorafenib and its metabolite M5 can predict treatment efficacy and the occurrence of skin toxicities (2019 · International Journal of Clinical Oncology · 被引 14)
Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors (2024 · Frontiers in Cell and Developmental Biology · 被引 6)
Association of the modified Glasgow prognostic score and prognostic nutritional index with duration of oral anamorelin administration in patients with cancer cachexia: a retrospective cohort study (2024 · Japanese Journal of Clinical Oncology · 被引 4)